Role of ATP-binding cassette transporter A1 in suppressing lipid accumulation by glucagon-like peptide-1 agonist in hepatocytes
Objective: Adenosine triphosphate (ATP)-binding cassette transporter A1 (ABCA1) influences hepatic cholesterol transportation. Accumulation of hepatic cholesterol leads to fatty liver disease, which is improved by glucagon-like peptide 1 (GLP-1) in diabetes. Therefore, we analyzed the molecular mech...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-04-01
|
Series: | Molecular Metabolism |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2212877820300016 |
_version_ | 1817987554921676800 |
---|---|
author | Jingya Lyu Hitomi Imachi Kensaku Fukunaga Seisuke Sato Toshihiro Kobayashi Tao Dong Takanobu Saheki Mari Matsumoto Hisakazu Iwama Huanxiang Zhang Koji Murao |
author_facet | Jingya Lyu Hitomi Imachi Kensaku Fukunaga Seisuke Sato Toshihiro Kobayashi Tao Dong Takanobu Saheki Mari Matsumoto Hisakazu Iwama Huanxiang Zhang Koji Murao |
author_sort | Jingya Lyu |
collection | DOAJ |
description | Objective: Adenosine triphosphate (ATP)-binding cassette transporter A1 (ABCA1) influences hepatic cholesterol transportation. Accumulation of hepatic cholesterol leads to fatty liver disease, which is improved by glucagon-like peptide 1 (GLP-1) in diabetes. Therefore, we analyzed the molecular mechanism in the regulation of hepatic ABCA1 by GLP-1 analogue exendin-4. Methods: Hepatic ABCA1 expression and transcription were checked by western blotting, real-time polymerase chain reaction (PCR), and luciferase assay in HepG2 cells. Chromatin immunoprecipitation (ChIP) and site-directed mutagenesis were employed to determine transcriptional regulation of the ABCA1 gene. Prolactin regulatory element-binding (PREB)-transgenic mice were generated to access the effect of exendin-4 on improving lipid accumulation caused by a high-fat diet (HFD). Results: Exendin-4 stimulated hepatic ABCA1 expression and transcription via the Ca2+/calmodulin (CaM)-dependent protein kinase kinase/CaM-dependent protein kinase IV (CaMKK/CaMKIV) pathway, whereas GLP-1 receptor antagonist exendin9-39 cancelled this effect. Therefore, exendin-4 decreased hepatic lipid content. ChIP showed that PREB could directly bind to the ABCA1 promoter, which was enhanced by exendin-4. Moreover, PREB stimulated ABCA1 promoter activity, and mutation of PREB-binding site in ABCA1 promoter cancelled exendin-4-enhanced ABCA1 promoter activity. Silencing of PREB attenuated the effect of exendin-4 and induced hepatic cholesterol accumulation. Blockade of CaMKK by STO-609 or siRNA cancelled the upregulation of ABCA1 and PREB induced by exendin-4. In vivo, exendin-4 or overexpression of PREB increased hepatic ABCA1 expression and decreased hepatic lipid accumulation and high plasma cholesterol caused by a HFD. Conclusions: Our data shows that exendin-4 stimulates hepatic ABCA1 expression and decreases lipid accumulation by the CaMKK/CaMKIV/PREB pathway, suggesting that ABCA1 and PREB might be the therapeutic targets in fatty liver disease. Keywords: Prolactin regulatory element-binding, Lipid accumulation, Non-alcoholic steatohepatitis, Fatty liver, Cell signaling |
first_indexed | 2024-04-14T00:22:54Z |
format | Article |
id | doaj.art-7ae39236ba2242d9a3f7a94bda3c86e8 |
institution | Directory Open Access Journal |
issn | 2212-8778 |
language | English |
last_indexed | 2024-04-14T00:22:54Z |
publishDate | 2020-04-01 |
publisher | Elsevier |
record_format | Article |
series | Molecular Metabolism |
spelling | doaj.art-7ae39236ba2242d9a3f7a94bda3c86e82022-12-22T02:22:53ZengElsevierMolecular Metabolism2212-87782020-04-01341626Role of ATP-binding cassette transporter A1 in suppressing lipid accumulation by glucagon-like peptide-1 agonist in hepatocytesJingya Lyu0Hitomi Imachi1Kensaku Fukunaga2Seisuke Sato3Toshihiro Kobayashi4Tao Dong5Takanobu Saheki6Mari Matsumoto7Hisakazu Iwama8Huanxiang Zhang9Koji Murao10Department of Endocrinology and Metabolism, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan; Department of Cell Biology, Jiangsu Key Laboratory of Stem Cell Research, Medical College of Soochow University, Ren Ai Road 199, Suzhou, 215123, China; Corresponding author. Department of Endocrinology and Metabolism, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan.Department of Endocrinology and Metabolism, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, JapanDepartment of Endocrinology and Metabolism, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, JapanDepartment of Endocrinology and Metabolism, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, JapanDepartment of Endocrinology and Metabolism, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, JapanDepartment of Endocrinology and Metabolism, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, JapanDepartment of Endocrinology and Metabolism, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, JapanDepartment of Endocrinology and Metabolism, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, JapanLife Science Research Center, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, JapanDepartment of Cell Biology, Jiangsu Key Laboratory of Stem Cell Research, Medical College of Soochow University, Ren Ai Road 199, Suzhou, 215123, ChinaDepartment of Endocrinology and Metabolism, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, JapanObjective: Adenosine triphosphate (ATP)-binding cassette transporter A1 (ABCA1) influences hepatic cholesterol transportation. Accumulation of hepatic cholesterol leads to fatty liver disease, which is improved by glucagon-like peptide 1 (GLP-1) in diabetes. Therefore, we analyzed the molecular mechanism in the regulation of hepatic ABCA1 by GLP-1 analogue exendin-4. Methods: Hepatic ABCA1 expression and transcription were checked by western blotting, real-time polymerase chain reaction (PCR), and luciferase assay in HepG2 cells. Chromatin immunoprecipitation (ChIP) and site-directed mutagenesis were employed to determine transcriptional regulation of the ABCA1 gene. Prolactin regulatory element-binding (PREB)-transgenic mice were generated to access the effect of exendin-4 on improving lipid accumulation caused by a high-fat diet (HFD). Results: Exendin-4 stimulated hepatic ABCA1 expression and transcription via the Ca2+/calmodulin (CaM)-dependent protein kinase kinase/CaM-dependent protein kinase IV (CaMKK/CaMKIV) pathway, whereas GLP-1 receptor antagonist exendin9-39 cancelled this effect. Therefore, exendin-4 decreased hepatic lipid content. ChIP showed that PREB could directly bind to the ABCA1 promoter, which was enhanced by exendin-4. Moreover, PREB stimulated ABCA1 promoter activity, and mutation of PREB-binding site in ABCA1 promoter cancelled exendin-4-enhanced ABCA1 promoter activity. Silencing of PREB attenuated the effect of exendin-4 and induced hepatic cholesterol accumulation. Blockade of CaMKK by STO-609 or siRNA cancelled the upregulation of ABCA1 and PREB induced by exendin-4. In vivo, exendin-4 or overexpression of PREB increased hepatic ABCA1 expression and decreased hepatic lipid accumulation and high plasma cholesterol caused by a HFD. Conclusions: Our data shows that exendin-4 stimulates hepatic ABCA1 expression and decreases lipid accumulation by the CaMKK/CaMKIV/PREB pathway, suggesting that ABCA1 and PREB might be the therapeutic targets in fatty liver disease. Keywords: Prolactin regulatory element-binding, Lipid accumulation, Non-alcoholic steatohepatitis, Fatty liver, Cell signalinghttp://www.sciencedirect.com/science/article/pii/S2212877820300016 |
spellingShingle | Jingya Lyu Hitomi Imachi Kensaku Fukunaga Seisuke Sato Toshihiro Kobayashi Tao Dong Takanobu Saheki Mari Matsumoto Hisakazu Iwama Huanxiang Zhang Koji Murao Role of ATP-binding cassette transporter A1 in suppressing lipid accumulation by glucagon-like peptide-1 agonist in hepatocytes Molecular Metabolism |
title | Role of ATP-binding cassette transporter A1 in suppressing lipid accumulation by glucagon-like peptide-1 agonist in hepatocytes |
title_full | Role of ATP-binding cassette transporter A1 in suppressing lipid accumulation by glucagon-like peptide-1 agonist in hepatocytes |
title_fullStr | Role of ATP-binding cassette transporter A1 in suppressing lipid accumulation by glucagon-like peptide-1 agonist in hepatocytes |
title_full_unstemmed | Role of ATP-binding cassette transporter A1 in suppressing lipid accumulation by glucagon-like peptide-1 agonist in hepatocytes |
title_short | Role of ATP-binding cassette transporter A1 in suppressing lipid accumulation by glucagon-like peptide-1 agonist in hepatocytes |
title_sort | role of atp binding cassette transporter a1 in suppressing lipid accumulation by glucagon like peptide 1 agonist in hepatocytes |
url | http://www.sciencedirect.com/science/article/pii/S2212877820300016 |
work_keys_str_mv | AT jingyalyu roleofatpbindingcassettetransportera1insuppressinglipidaccumulationbyglucagonlikepeptide1agonistinhepatocytes AT hitomiimachi roleofatpbindingcassettetransportera1insuppressinglipidaccumulationbyglucagonlikepeptide1agonistinhepatocytes AT kensakufukunaga roleofatpbindingcassettetransportera1insuppressinglipidaccumulationbyglucagonlikepeptide1agonistinhepatocytes AT seisukesato roleofatpbindingcassettetransportera1insuppressinglipidaccumulationbyglucagonlikepeptide1agonistinhepatocytes AT toshihirokobayashi roleofatpbindingcassettetransportera1insuppressinglipidaccumulationbyglucagonlikepeptide1agonistinhepatocytes AT taodong roleofatpbindingcassettetransportera1insuppressinglipidaccumulationbyglucagonlikepeptide1agonistinhepatocytes AT takanobusaheki roleofatpbindingcassettetransportera1insuppressinglipidaccumulationbyglucagonlikepeptide1agonistinhepatocytes AT marimatsumoto roleofatpbindingcassettetransportera1insuppressinglipidaccumulationbyglucagonlikepeptide1agonistinhepatocytes AT hisakazuiwama roleofatpbindingcassettetransportera1insuppressinglipidaccumulationbyglucagonlikepeptide1agonistinhepatocytes AT huanxiangzhang roleofatpbindingcassettetransportera1insuppressinglipidaccumulationbyglucagonlikepeptide1agonistinhepatocytes AT kojimurao roleofatpbindingcassettetransportera1insuppressinglipidaccumulationbyglucagonlikepeptide1agonistinhepatocytes |